EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Oncological outcome of vocal cord-only radiotherapy for cT1-T2 glottic laryngeal squamous cell carcinoma

Mischa de Ridder, Johannes A Rijken, Hilde J G Smits, Ernst J Smid, Patricia A H Doornaert, Remco de Bree

European Archives of Oto-Rhino-Laryngology · 2023

DOI: 10.1007/s00405-023-07904-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Archives of Oto-Rhino-Laryngology, 2023. Verfasst von Mischa de Ridder und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiotherapy, University Medical Center Utrecht, Heidelberglaan 100, Postbox 85500, 3508 GA, Utrecht, The Netherlands. m.deridder-5@umc…. Hauptthemen laut MEDLINE: Laryngeal Neoplasms, Head and Neck Neoplasms. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Early-stage glottic cancer can be treated with radiotherapy only. Modern radiotherapy solutions allow for individualized dose distributions, hypofractionation and sparing of organs at risk. The target volume used to be the entire voice box. This series describe the oncological outcome and toxicity of individualized vocal cord-only hypofractionated radiotherapy for early stage (cT1a-T2 N0).

Methods

Retrospective cohort study with patients treated in a single center between 2014 and 2020.

Results

A total of 93 patients were included. Local control rate was 100% for cT1a, 97% for cT1b and 77% for cT2. Risk factor for local recurrence was smoking during radiotherapy. Laryngectomy-free survival was 90% at 5 years. Grade III or higher late toxicity was 3.7%.

Conclusion

Vocal cord-only hypofractionated radiotherapy appears to be oncologically safe in early-stage glottic cancer. Modern, image-guided radiotherapy led to comparable results as historical series with very limited late toxicity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Laryngeal NeoplasmsHead and Neck NeoplasmsHumansVocal CordsSquamous Cell Carcinoma of Head and NeckRetrospective StudiesGlottisTreatment OutcomeNeoplasm Recurrence, LocalNeoplasm Staging

Stichwörter der Autor:innen

Glottic cancerLarynxRadiotherapyVMATVocal cord

Autor:innen und Institutionen

  • Department of Radiotherapy, University Medical Center Utrecht, Heidelberglaan 100, Postbox 85500, 3508 GA, Utrecht, The Netherlands. m.deridder-5@umcutrecht.nl.
  • Department of Head and Neck Surgical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Department of Radiotherapy, University Medical Center Utrecht, Heidelberglaan 100, Postbox 85500, 3508 GA, Utrecht, The Netherlands.

Zitieren

APA

de Ridder, M., Rijken, J. A., Smits, H. J. G., Smid, E. J., Doornaert, P. A. H., & de Bree, R. (2023). Oncological outcome of vocal cord-only radiotherapy for cT1-T2 glottic laryngeal squamous cell carcinoma. European Archives of Oto-Rhino-Laryngology. https://doi.org/10.1007/s00405-023-07904-2

Vancouver

de Ridder M, Rijken JA, Smits HJG, Smid EJ, Doornaert PAH, de Bree R. Oncological outcome of vocal cord-only radiotherapy for cT1-T2 glottic laryngeal squamous cell carcinoma. European Archives of Oto-Rhino-Laryngology. 2023. doi:10.1007/s00405-023-07904-2

BibTeX
@article{deRidder2023,
  author = {de Ridder, Mischa and Rijken, Johannes A and Smits, Hilde J G and Smid, Ernst J and Doornaert, Patricia A H and de Bree, Remco},
  title = {Oncological outcome of vocal cord-only radiotherapy for cT1-T2 glottic laryngeal squamous cell carcinoma},
  journal = {European Archives of Oto-Rhino-Laryngology},
  year = {2023},
  doi = {10.1007/s00405-023-07904-2}
}
Kostenlos starten →